Cytologic localization of epidermal growth factor and its receptor in developing human placenta varies over the course of pregnancy.
Cytologic localization of epidermal growth factor and its receptor in developing human placenta was analyzed by avidin-biotin immunoperoxidase techniques with a polyclonal antibody to epidermal growth factor and a monoclonal antibody to its receptor. In 4- to 5-week placenta, epidermal growth factor and its receptor were found to be almost exclusively localized to cytotrophoblasts, whereas in 6- to 12-week placentas they were predominantly localized to syncytiotrophoblasts. These findings suggest that both are initially expressed in cytotrophoblasts in very early placenta before 6 weeks' gestation and thereafter expressed in syncytiotrophoblasts in 6- to 12-week placentas. Their simultaneous expression in the cytotrophoblast of 4- to 5-week placentas and in the syncytiotrophoblast of 6- to 12-week placentas implies that epidermal growth factor may act in an autocrine manner in first-trimester placentas. By contrast, in second- and third-trimester placentas, epidermal growth factor was mainly localized to cytotrophoblasts, whereas its receptor was predominantly localized to syncytiotrophoblasts. These findings imply that epidermal growth factor may act in a paracrine fashion in second- and third-trimester placentas. The dynamic change in cytologic localization of epidermal growth factor and epidermal growth factor receptor in developing human placentas may reflect the change in a possible role of epidermal growth factor in the course of fetoplacental development.